LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 171 filers reported holding LEGEND BIOTECH CORP in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,827,267 | -31.0% | 310,068 | -29.1% | 0.01% | -16.7% |
| Q2 2023 | $30,200,694 | +135.5% | 437,501 | +64.5% | 0.01% | +100.0% |
| Q1 2023 | $12,825,845 | +24.5% | 265,986 | +28.9% | 0.00% | +50.0% |
| Q4 2022 | $10,303,638 | -54.6% | 206,403 | -62.9% | 0.00% | -60.0% |
| Q3 2022 | $22,712,000 | -1.3% | 556,658 | +33.1% | 0.01% | 0.0% |
| Q2 2022 | $23,008,000 | +72.6% | 418,328 | +14.0% | 0.01% | +66.7% |
| Q1 2022 | $13,332,000 | +30.6% | 366,864 | +67.5% | 0.00% | +50.0% |
| Q4 2021 | $10,209,000 | +169.8% | 219,034 | +192.7% | 0.00% | +100.0% |
| Q3 2021 | $3,784,000 | +71.5% | 74,844 | +39.2% | 0.00% | – |
| Q2 2021 | $2,207,000 | +808.2% | 53,757 | +542.9% | 0.00% | – |
| Q1 2021 | $243,000 | -40.4% | 8,362 | -42.3% | 0.00% | – |
| Q4 2020 | $408,000 | – | 14,483 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |